CSIRO Animal, Food and Health Sciences, Preventative Health Flagship, North Ryde, NSW 1670, Australia.
Nucleic Acids Res. 2013 Jan 7;41(1):e15. doi: 10.1093/nar/gks831. Epub 2012 Sep 10.
We have developed a novel technique for specific amplification of rare methylated DNA fragments in a high background of unmethylated sequences that avoids the need of bisulphite conversion. The methylation-dependent restriction enzyme GlaI is used to selectively cut methylated DNA. Then targeted fragments are tagged using specially designed 'helper' oligonucleotides that are also used to maintain selection in subsequent amplification cycles in a process called 'helper-dependent chain reaction'. The process uses disabled primers called 'drivers' that can only prime on each cycle if the helpers recognize specific sequences within the target amplicon. In this way, selection for the sequence of interest is maintained throughout the amplification, preventing amplification of unwanted sequences. Here we show how the method can be applied to methylated Septin 9, a promising biomarker for early diagnosis of colorectal cancer. The GlaI digestion and subsequent amplification can all be done in a single tube. A detection sensitivity of 0.1% methylated DNA in a background of unmethylated DNA was achieved, which was similar to the well-established Heavy Methyl method that requires bisulphite-treated DNA.
我们开发了一种新的技术,可特异性扩增高度未甲基化序列背景下的稀有甲基化 DNA 片段,而无需亚硫酸氢盐转化。依赖甲基化的限制性内切酶 GlaI 用于选择性切割甲基化 DNA。然后使用专门设计的“辅助”寡核苷酸标记靶向片段,该寡核苷酸也用于在后续扩增循环中维持选择,这一过程称为“辅助依赖性链反应”。该过程使用称为“驱动”的失活引物,只有在辅助物识别靶扩增子内的特定序列时,引物才能在每个循环上进行引物延伸。通过这种方式,在整个扩增过程中维持了对感兴趣序列的选择,防止了非期望序列的扩增。本文展示了该方法如何应用于甲基化 Septin 9,这是结直肠癌早期诊断有前途的生物标志物。GlaI 消化和随后的扩增都可以在单个管中进行。在未甲基化 DNA 的背景下,实现了 0.1%甲基化 DNA 的检测灵敏度,与需要亚硫酸氢盐处理 DNA 的成熟的 Heavy Methyl 方法相似。